Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.

Common baldness is a hereditary condition that can be treated with medications or surgery to prevent progression and improve self-esteem.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

Spironolactone may be effective for acne and other skin conditions and could be used more in treatment.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Spironolactone is a promising alternative to antibiotics for treating acne in adult females.

Spironolactone may be a better acne treatment for adult women than antibiotics.

Menopausal acne is mainly caused by hormonal changes and can be managed with topical treatments, lifestyle changes, and sometimes medication.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Glucocorticoid treatment lowered androgen levels but didn't improve hirsutism or ovulation and caused weight gain.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Stopping the drug usually helps, but tamoxifen or surgery may be needed if symptoms persist.

Some elderly men had healing problems after using imiquimod and diclofenac for skin conditions on their scalps.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

A patient with HAIR-AN syndrome, PCOS, and Hashimoto's thyroiditis improved with early diagnosis and treatment to prevent serious health problems.

Older men with scalp wounds had long-term healing problems after using imiquimod or diclofenac for skin cancer prevention.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

Hair loss in women can be treated with hormone therapy.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Treatment improved symptoms in a woman with HAIR-AN syndrome.

Spironolactone helped reduce excessive facial hair in a woman with porphyria cutanea tarda.

Spironolactone was effective in reducing hair growth in women with hirsutism.